Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Hybrigenics SA R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.	France	ALHYG
Hyundai ADM Bio lnc. Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.	South Korea	187660
HYUNDAI BIOSCIENCE CO., LTD. Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.	South Korea	048410
iBio, Inc. AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.	United States of America	IBIO
Ibotta, Inc. A performance marketing platform offering cash-back rewards to consumers from CPG brands.	United States of America	IBTA
ICON PLC Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.	United States of America	ICLR
IDEAYA Biosciences, Inc. Clinical-stage firm developing precision cancer therapies via synthetic lethality.	United States of America	IDYA
IMGT Corporation Limited Develops a drug delivery platform using ultrasound and nanotech for oncology.	South Korea	456570
IMMERSION CORP Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.	United States of America	IMMR
IMMUNIC, INC. Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.	United States of America	IMUX